CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY. (2025). International Journal of Medical Sciences, 5(05), 396-403. https://doi.org/10.55640/